Provided by Tiger Trade Technology Pte. Ltd.

Apogee Therapeutics

135.08
0.0000
Post-market: 135.06-0.0193-0.01%17:22 EDT
Volume:1.08M
Turnover:145.56M
Market Cap:10.18B
PE:-31.12
High:135.09
Open:135.03
Low:135.01
Close:135.08
52wk High:135.09
52wk Low:35.39
Shares:75.34M
Float Shares:58.14M
Volume Ratio:0.91
T/O Rate:1.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3400
EPS(LYR):-4.2155
ROE:-32.46%
ROA:-20.30%
PB:8.52
PE(LYR):-32.04

Loading ...

US STOCKS-S&P 500, Dow tick higher as investors weigh Mideast negotiations

Reuters
·
Jun 22

Movement Alert|Apogee Therapeutics Intraday Rise 46.61%, AbbVie Announces $10.9 Billion All-Cash Acquisition at 60% Premium

Market Focus
·
Jun 22

Abbvie Shares up 3.1%

THOMSON REUTERS
·
Jun 22

Apogee Therapeutics Shares Jump 46.6% After Abbvie to Buy Co in $11 Bln Deal

THOMSON REUTERS
·
Jun 22

Apogee Therapeutics Inc : Canaccord Genuity Cuts to Hold From Buy; Raises Target Price to $135.11 From $130

THOMSON REUTERS
·
Jun 22

Canaccord Genuity Downgrades Apogee Therapeutics to Hold From Buy, Adjusts Price Target to $135.11 From $130

MT Newswires Live
·
Jun 22

Apogee Therapeutics downgraded to Hold from Buy at Canaccord

TIPRANKS
·
Jun 22

Sector Update: Healthcare

MT Newswires Live
·
Jun 22

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Amid Continued US-Iran Talks

MT Newswires Live
·
Jun 22

BUZZ-U.S. STOCKS ON THE MOVE- Visteon, Incyte, Apogee

Reuters
·
Jun 22

BRIEF-Apogee Therapeutics - Enters Il-31R License Agreement With Paragon On June 17, 2026 - SEC Filing

Reuters
·
Jun 22

BRIEF-Abbvie To Acquire Apogee Therapeutics, Deepening Immunology Portfolio

Reuters
·
Jun 22

AbbVie is buying a biotech working on an experimental eczema drug for $10.9 billion

Dow Jones
·
Jun 22

Apogee Therapeutics : Under Abbvie Deal, Co to Pay Andor Termination Fee of $381.3 Mln IF Deal Is Terminated Under Certain Circumstances - SEC Filing

THOMSON REUTERS
·
Jun 22

Apogee's Dosing Convenience Drives Value in AbbVie's New Lead Asset -- Company Talk

Dow Jones
·
Jun 22

AbbVie Bets Big on Respiratory Pipeline with Apogee Acquisition -- Company Talk

Dow Jones
·
Jun 22

AbbVie's $10.9 Billion Apogee Therapeutics Buyout Protects Its Immunology Crown -- Barrons.com

Dow Jones
·
Jun 22

US STOCKS-Wall St futures muted as investors monitor US-Iran negotiations

Reuters
·
Jun 22

S&P 500 Futures Fall In Premarket Trading; Apogee Therapeutics, Fervo Energy Lead

Dow Jones
·
Jun 22

Apogee Therapeutics - to Pay Paragon up to $23.25 Mln for Milestones Under Il-31R License Agreement - SEC Filing

THOMSON REUTERS
·
Jun 22